vs

Side-by-side financial comparison of AURORA CANNABIS INC (ACB) and Cardlytics, Inc. (CDLX). Click either name above to swap in a different company.

AURORA CANNABIS INC is the larger business by last-quarter revenue ($81.6M vs $50.9M, roughly 1.6× Cardlytics, Inc.). Cardlytics, Inc. produced more free cash flow last quarter ($13.0M vs $-8.6M).

Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. ...

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

ACB vs CDLX — Head-to-Head

Bigger by revenue
ACB
ACB
1.6× larger
ACB
$81.6M
$50.9M
CDLX
More free cash flow
CDLX
CDLX
$21.6M more FCF
CDLX
$13.0M
$-8.6M
ACB

Income Statement — Q1 FY2024 vs Q4 FY2025

Metric
ACB
ACB
CDLX
CDLX
Revenue
$81.6M
$50.9M
Net Profit
$-617.0M
Gross Margin
8.7%
Operating Margin
-73.7%
-12.0%
Net Margin
-756.4%
Revenue YoY
-25.5%
Net Profit YoY
EPS (diluted)
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACB
ACB
CDLX
CDLX
Q4 25
$50.9M
Q3 25
$47.0M
Q2 25
$58.0M
Q1 25
$56.4M
Q4 24
$68.3M
Q3 24
$61.1M
Q2 24
$64.0M
Q1 24
$62.2M
Net Profit
ACB
ACB
CDLX
CDLX
Q4 25
Q3 25
$-72.7M
Q2 25
$-9.3M
Q1 25
$-13.3M
Q4 24
Q3 24
$-145.2M
Q2 24
$-4.3M
Q1 24
$-24.3M
Operating Margin
ACB
ACB
CDLX
CDLX
Q4 25
-12.0%
Q3 25
-146.6%
Q2 25
-22.0%
Q1 25
-24.9%
Q4 24
-12.2%
Q3 24
-243.1%
Q2 24
-24.7%
Q1 24
-36.7%
Net Margin
ACB
ACB
CDLX
CDLX
Q4 25
Q3 25
-154.7%
Q2 25
-16.0%
Q1 25
-23.5%
Q4 24
Q3 24
-237.6%
Q2 24
-6.7%
Q1 24
-39.0%
EPS (diluted)
ACB
ACB
CDLX
CDLX
Q4 25
$-0.15
Q3 25
$-1.36
Q2 25
$-0.18
Q1 25
$-0.26
Q4 24
$-0.36
Q3 24
$-2.90
Q2 24
$-0.09
Q1 24
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACB
ACB
CDLX
CDLX
Cash + ST InvestmentsLiquidity on hand
$48.7M
Total DebtLower is stronger
$212.6M
Stockholders' EquityBook value
$-6.5M
Total Assets
$285.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACB
ACB
CDLX
CDLX
Q4 25
$48.7M
Q3 25
$44.0M
Q2 25
$46.7M
Q1 25
$52.0M
Q4 24
$65.6M
Q3 24
$67.0M
Q2 24
$71.2M
Q1 24
$97.8M
Total Debt
ACB
ACB
CDLX
CDLX
Q4 25
$212.6M
Q3 25
$214.6M
Q2 25
$214.3M
Q1 25
$213.9M
Q4 24
$213.6M
Q3 24
$213.2M
Q2 24
$212.9M
Q1 24
$257.9M
Stockholders' Equity
ACB
ACB
CDLX
CDLX
Q4 25
$-6.5M
Q3 25
$-4.7M
Q2 25
$58.7M
Q1 25
$64.1M
Q4 24
$70.0M
Q3 24
$69.7M
Q2 24
$210.0M
Q1 24
$199.1M
Total Assets
ACB
ACB
CDLX
CDLX
Q4 25
$285.6M
Q3 25
$292.8M
Q2 25
$361.1M
Q1 25
$369.1M
Q4 24
$392.7M
Q3 24
$399.4M
Q2 24
$534.4M
Q1 24
$569.0M
Debt / Equity
ACB
ACB
CDLX
CDLX
Q4 25
Q3 25
Q2 25
3.65×
Q1 25
3.34×
Q4 24
3.05×
Q3 24
3.06×
Q2 24
1.01×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACB
ACB
CDLX
CDLX
Operating Cash FlowLast quarter
$-4.3M
$13.0M
Free Cash FlowOCF − Capex
$-8.6M
$13.0M
FCF MarginFCF / Revenue
-10.6%
25.5%
Capex IntensityCapex / Revenue
5.3%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACB
ACB
CDLX
CDLX
Q4 25
$13.0M
Q3 25
$1.8M
Q2 25
$1.2M
Q1 25
$-6.7M
Q4 24
$3.0M
Q3 24
$1.4M
Q2 24
$4.4M
Q1 24
$-17.6M
Free Cash Flow
ACB
ACB
CDLX
CDLX
Q4 25
$13.0M
Q3 25
$1.7M
Q2 25
$903.0K
Q1 25
$-6.8M
Q4 24
$2.9M
Q3 24
$878.0K
Q2 24
$4.1M
Q1 24
$-18.3M
FCF Margin
ACB
ACB
CDLX
CDLX
Q4 25
25.5%
Q3 25
3.7%
Q2 25
1.6%
Q1 25
-12.1%
Q4 24
4.2%
Q3 24
1.4%
Q2 24
6.5%
Q1 24
-29.4%
Capex Intensity
ACB
ACB
CDLX
CDLX
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.6%
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.8%
Q2 24
0.4%
Q1 24
1.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons